Search
Cystine
go.drugbank.com/drugs/DB00138ApprovedInvestigationalNutraceuticalWithdrawnA covalently linked dimeric nonessential amino acid formed by the oxidation of cysteine. Two molecules of cysteine are joined together by a disulfide bridge to form cystine.
Categories: Amino Acids, Peptides, and ProteinsGadoteridol
go.drugbank.com/drugs/DB00597ApprovedInvestigationalGadoteridol is a macrocyclic nonionic gadolinium that provides contrast enhancement of the brain, spine, and surrounding tissues, resulting in improved visualization (compared with unenhanced MRI) of lesions … [A263076] Initially approved by the FDA in 1992, gadoteridol received additional approval in 2020 for use in pediatric patients less than 2 years old.[L49876]
Daraxonrasib
go.drugbank.com/drugs/DB22308ApprovedInvestigational[L64039,L64040] It is the first targeted cancer medicine approved from the class of RAS(ON) multi-selective and mutant-selective inhibitors.[L64041] … [L64040,L64041] It is taken by mouth once daily.
Pork collagen
go.drugbank.com/drugs/DB14100ApprovedThe surgical implantation shows a tolerable safety profile and efficacy up to 4 years, but it is not indicated for patients with osteoarthritis. … It has been used since 1995 as Carticel and gained biologic license in 1997. The surgical implantation was first performed in Sweden.
Daclizumab
go.drugbank.com/drugs/DB00111ApprovedInvestigationalWithdrawnThe human sequences were derived from the constant domains of human IgG1 and the variable framework regions of the Eu myeloma antibody. … Although Zinbryta (daclizumab) was available for patients as needed until 30 April 2018, Biogen and Abbvie announced a voluntary withdrawal of their product Zinbryta (daclizumab) from the global market
Categories: Amino Acids, Peptides, and Proteins, Antineoplastic and Immunomodulating AgentsProducts: Zenapax 5mg/mlCopper gluconate
go.drugbank.com/drugs/DB11246ApprovedInvestigationalAccording to the good manufacturing or feeding practice by the FDA, copper gluconate is used as a nutrient or dietary supplement and is generally recognized as safe for use at a level not exceeding 0.005 … It is prepared by the reaction of gluconic acid solutions with cupric oxide or basic cupric carbonate.
Mixtures: Super 7 Vitamin and Mineral Supplement, Multivitamins and Minerals for Young WomenAcipimox
go.drugbank.com/drugs/DB09055ApprovedInvestigationalAcipimox inhibits the production of triglycerides by the liver and the secretion of VLDL, which leads indirectly to a modest reduction in LDL and increase in HDL. … Long-term administration is associated with reduced mortality, but unwanted effects limit its clinical use.
Categories: Nicotinic Acid and DerivativesPerfluorohexyloctane
go.drugbank.com/drugs/DB17823ApprovedInvestigationalPerfluorohexyloctane is a semifluorinated alkane that contains six perfluorinated carbon atoms and eight hydrogenated carbon atoms.[L46491] It is an inert, slightly amphiphilic compound. … [A259741] It was approved by the FDA on May 18, 2023 for the treatment of dry eye disease.[L46536]
Categories: Ophthalmological and Otological PreparationsPhenylbutyric acid
go.drugbank.com/drugs/DB06819ApprovedInvestigationalPhenylbutyric acid is a fatty acid and a derivative of [butyric acid] naturally produced by colonic bacteria fermentation. … It demonstrates a number of cellular and biological effects, such as relieving inflammation and acting as a chemical chaperone.
Categories: Alimentary Tract and Metabolism, sodium phenylbutyrate and ursodoxicoltaurineFaropenem medoxomil
go.drugbank.com/drugs/DB05659InvestigationalIt is being developed jointly by Replidyne, Inc. and Forest Laboratories, Inc. … The prodrug form of faropenem offers dramatically improved oral bioavailability and leads to higher systemic concentrations of the drug.